Recomienda este artículo a tus amigos:
Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development N Ferrari
Precio
Mex$ 3.898
sin IVA
Pedido desde almacén remoto
Entrega prevista 27 de jul. - 12 de ago.
Recibe notificaciones sobre nuevos lanzamientos de N Ferrari
Nuestros clientes opinan:
Añadir a tu lista de deseos de iMusic
Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development
N Ferrari
Antisense-based drugs are part of a growing number of pharmaceutical and biotech programs to treat diseases including cancer, diabetes, and ALS. Reviewing fundamentals and offering guidelines for drug discovery and development, this book is a practical guide from the safety assessment to clinical experience with antisense oligonucleotides.
576 pages
| Medios de comunicación | Libros Hardcover Book (Libro con lomo y cubierta duros) |
| Publicado | 31 de julio de 2018 |
| ISBN13 | 9781118537336 |
| Editores | John Wiley & Sons Inc |
| Páginas | 576 |
| Dimensiones | 160 × 231 × 33 mm · 898 g |
| Lengua | Inglés |
| Editor | Ferrari, Nicolay |
| Editor | Seguin, Rosanne |
